Molecular and Genomic Interrogation of Childhood Cancer – Ireland | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

604,789 results for “Molecular and Genomic Interrogation of Childhood Cancer – Ireland”

Ireland Launches MAGIC-I: First National Genomics Study to Transform Childhood Cancer Care

Ireland Launches Phase 2 of Precision Oncology Ireland Program with Expanded Investment and Clinical Focus

Molecular Profiling and Advanced Imaging Guide Personalized Treatment in Complex Secondary Meningioma After Childhood Medulloblastoma

Silmitasertib Trial Launched for Childhood Solid Tumors

Childhood Cancer Survivors Face Five-Fold Higher Risk of Kidney Disease and Hypertension

Personalised Medicine and PARP Inhibitors Transform Stage IV Breast Cancer Outcomes: A Decade of Progress in Northern Ireland

New Clinical Trial Tests Tipifarnib and Naxitamab Combination for Neuroblastoma

Molecular Profiling Revolutionizes Cancer Treatment: AI and Precision Medicine Shape Future of Oncology

Precision Genomic Profiling Reveals Multiple Molecular Diagnoses in Gaucher Disease Patients with Atypical Presentations

NCI Highlights Blinatumomab and Atezolizumab Advances as Childhood Cancer Data Initiative Scales Up

Page 1 of 4084